On Chip Bioelectric Impedance Spectroscopy Reveals the Effect of P-Glycoprotein Efflux Pumps on the Paracellular Impedance of Tight Junctions at the Blood-Brain Barrier

被引:7
作者
Kraya, Ramsey [1 ,2 ]
Komin, Alexander [2 ,3 ]
Searson, Peter [2 ,3 ]
机构
[1] Johns Hopkins Univ, Dept Biomed Engn, Baltimore, MD 21218 USA
[2] Johns Hopkins Univ, Inst Nanobiotechnol, Baltimore, MD 21218 USA
[3] Johns Hopkins Univ, Dept Mat Sci & Engn, Baltimore, MD 21218 USA
基金
美国国家卫生研究院;
关键词
Bioimpedance; cells (biology); drug delivery; TYROSINE PHOSPHATASE INHIBITION; ENDOTHELIAL-CELLS; EPITHELIAL-CELLS; TUMOR-CELLS; OCCLUDIN; PHOSPHORYLATION; PERMEABILITY; TRANSPORT; PATHWAYS; BILAYERS;
D O I
10.1109/TNB.2016.2604322
中图分类号
Q5 [生物化学];
学科分类号
071010 ; 081704 ;
摘要
Bioelectric impedance spectroscopy was used to elucidate the influence of P-gp efflux pumps on the kinetics of tight junction down-regulation in confluent monolayers of Madine Darby Canine Kidney Epithelial Cells (MDCK) following administration of phenylarsine oxide (PAO), a molecule that inhibits protein tyrosine phosphatases (PTP) and induces matrix metalloproteinase activity. Matrix metalloproteinases (MMPs) and phosphatase inhibitors induce modification of occludin tight junction proteins critical for the proper function of the blood-brain barrier. The addition of PAO to MDCKII cell lines resulted in a dramatic decrease in monolayer resistance. In contrast, MDCKII-MDR1 cells transfected with the MDR1 gene treated with PAO showed an initial decrease in monolayer resistance followed by a partial recovery and subsequent decrease. This resistance decay reversal was suppressed with the addition of the P-glycoprotein (P-gp) pump inhibitor elacridar, and is attributed to PAO efflux. These results illustrate impedance spectroscopy can be used to characterize the competing kinetics of efflux and down-regulation of tight junctions. In addition, the resistance decay reversal effect can be used to evaluate P-gp pump inhibitor efficacy.
引用
收藏
页码:697 / 703
页数:7
相关论文
共 50 条
[21]   Blood-brain barrier penetration of the enantiomers of venlafaxine and its metabolites in mice lacking P-glycoprotein [J].
Karlsson, Louise ;
Schmitt, Ulrich ;
Josefsson, Martin ;
Carlsson, Bjorn ;
Ahlner, Johan ;
Bengtsson, Finn ;
Kugelberg, Fredrik C. ;
Hiemke, Christoph .
EUROPEAN NEUROPSYCHOPHARMACOLOGY, 2010, 20 (09) :632-640
[22]   Imaging the impact of blood-brain barrier disruption induced by focused ultrasound on P-glycoprotein function [J].
Goutal, Sebastien ;
Novell, Anthony ;
Leterrier, Sarah ;
Breuil, Louise ;
Selingue, Erwan ;
Gerstenmayer, Matthieu ;
Marie, Solene ;
Saubamea, Bruno ;
Caille, Fabien ;
Langer, Oliver ;
Truillet, Charles ;
Larrat, Benoit ;
Tournier, Nicolas .
JOURNAL OF CONTROLLED RELEASE, 2023, 361 :483-492
[23]   Involvement of Moesin in the Development of Morphine Analgesic Tolerance through P-glycoprotein at the Blood-Brain Barrier [J].
Kobori, Takuro ;
Fujiwara, Shuhei ;
Miyagi, Kei ;
Harada, Shinichi ;
Nakamoto, Kazuo ;
Nakagawa, Takayuki ;
Takahashi, Hideo ;
Narita, Minoru ;
Tokuyama, Shogo .
DRUG METABOLISM AND PHARMACOKINETICS, 2014, 29 (06) :482-489
[24]   Uptake characteristics of pinocembrin and its effect on p-glycoprotein at the blood-brain barrier in in vitro cell experiments [J].
Yang, Zhi-Hong ;
Sun, Xiao ;
Qi, Yun ;
Mei, Chao ;
Sun, Xiao-Bo ;
Du, Guan-Hua .
JOURNAL OF ASIAN NATURAL PRODUCTS RESEARCH, 2012, 14 (01) :14-21
[25]   Inhibition of P-glycoprotein:: Rapid assessment of its implication in blood-brain barrier integrity and drug transport to the brain by an in vitro model of the blood-brain barrier [J].
Fenart, L ;
Buée-Scherrer, V ;
Descamps, L ;
Duhem, C ;
Poullain, MG ;
Cecchelli, R ;
Dehouck, MP .
PHARMACEUTICAL RESEARCH, 1998, 15 (07) :993-1000
[26]   Inhibition of P-Glycoprotein: Rapid Assessment of Its Implication in Blood-Brain Barrier Integrity and Drug Transport to the Brain by an In Vitro Model of the Blood-Brain Barrier [J].
Laurence Fenart ;
Valeric Buée-Scherrer ;
Laurence Descamps ;
Christian Duhem ;
Marie-Gwenaëlle Poullain ;
Roméo Cecchelli ;
Marie-Pierre Dehouck .
Pharmaceutical Research, 1998, 15 :993-1000
[27]   In Vitro and In Vivo Evidence for Amphotericin B as a P-Glycoprotein Substrate on the Blood-Brain Barrier [J].
Wu, Ji-Qin ;
Shao, Kun ;
Wang, Xuan ;
Wang, Rui-Ying ;
Cao, Ya-Hui ;
Yu, Yun-Qiu ;
Lou, Jin-Ning ;
Chen, Yan-Qiong ;
Zhao, Hua-Zhen ;
Zhang, Qiang-Qiang ;
Weng, Xin-Hua ;
Jiang, Chen ;
Zhu, Li-Ping .
ANTIMICROBIAL AGENTS AND CHEMOTHERAPY, 2014, 58 (08) :4464-4469
[28]   Influence of time to achieve substrate distribution equilibrium between brain tissue and blood on quantitation of the blood-brain barrier P-glycoprotein effect [J].
Padowski, Jeannie M. ;
Pollack, Gary M. .
BRAIN RESEARCH, 2011, 1426 :1-17
[29]   Penetration of verapamil across blood brain barrier following cerebral ischemia depending on both paracellular pathway and P-glycoprotein transportation [J].
Fang, Weirong ;
Lv, Peng ;
Geng, Xiaohan ;
Shang, Erxin ;
Yang, Qichuan ;
Sha, Lan ;
Li, Yunman .
NEUROCHEMISTRY INTERNATIONAL, 2013, 62 (01) :23-30
[30]   A Comparison of the Effects of P-Glycoprotein Inhibitors on the Blood-Brain Barrier Permeation of Cyclic Prodrugs of an Opioid Peptide (DADLE) [J].
Ouyang, Hui ;
Andersen, Thomas E. ;
Chen, Weiqing ;
Nofsinger, Reecca ;
Steffansen, Bente ;
Borchardt, Ronald T. .
JOURNAL OF PHARMACEUTICAL SCIENCES, 2009, 98 (06) :2227-2236